AIMM Therapeutics Presents Preclinical Data on its Four Oncology Therapies at AACR’s Annual Meeting Session on Antibody Technologies --World-Class Monoclonal Antibody Technology Advances Beyond Infectious Disease to Focus on Oncology Therapeutics Derived from Cancer Survivors-- --Lead Asset AT1412 On Track Towards CTA Filing in...